IthaID: 1121


Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: Variant of Uncertain Significance
Common Name: CD 95 AAG>AAY [Lys>Asn] HGVS Name: HBB:c.288G>Y
Hb Name: Hb Detroit Protein Info: β 95(FG2) Lys>Asn

Context nucleotide sequence:
CACTGAGTGAGCTGCACTGTGACAA [G>C] CTGCACGTGGATCCTGAGAACTTCA (Strand: -)

Protein sequence:
MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDNLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH

Also known as:

Comments: Reported as a β95 (FG2) Lys>Asn [AAG>AAC or AAT] change by amino acid analysis in a female subject from India without hematological abnormalities. The variant Hb was detected by cellulose acetate electrophoresis and column chromatography on DEAE-Sephadex. It was shown to migrate between Hb A and Hb J Baltimore. Could not be detected by electrophoresis on citrate agar gel. Hb stability tests and oxygen affinity studies were normal.

We follow the HGVS sequence variant nomenclature and IUPAC standards.

Phenotype

Hemoglobinopathy Group: Structural Haemoglobinopathy
Hemoglobinopathy Subgroup: β-chain variant
Allele Phenotype:N/A
Stability: N/A
Oxygen Affinity: N/A
Associated Phenotypes: N/A

Location

Chromosome: 11
Locus: NG_000007.3
Locus Location: 71012
Size: 1 bp
Located at: β
Specific Location: Exon 2

Other details

Type of Mutation: Point-Mutation(Substitution)
Effect on Gene/Protein Function: N/A
Ethnic Origin: Indian
Molecular mechanism: N/A
Inheritance: Recessive
DNA Sequence Determined: No

In silico pathogenicity prediction

Publications / Origin

  1. Moo-Penn WF, Schneider RG, Andrian S, Das DK, Hemoglobin Detroit: beta95 (FG2) lysine leads to asparagine., Biochimica et biophysica acta, 536(1), 283-8, 1978
Created on 2010-06-16 16:13:16, Last reviewed on 2023-06-09 13:12:42 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.